BlinkLab

Marking another step toward FDA clearance for its autism diagnostic tool.

BlinkLab has entered into an academic research agreement with Erasmus University Medical Center, a world-renowned medical research institution in The Netherlands.

Founders share insights on BlinkLab’s autism spectrum research journey

Managing Director & CEO of BlinkLab Limited, Dr Henk-Jan Boele, has been invited to speak at a prestigious in-person scientific workshop hosted by the SimonsFoundation Autism Research Initiative (SFARI) in New York City, USA.

BlinkLab offers career opportunities and builds tools intended to advance mental health worldwide.

Dr. Abdeslem El Idrissi is a professor of Neuroscience at the City University of New York.

I hold a Master’s degree in Journalism from Moscow State University.

Dr. Uvarov, a neuroscience-focused healthcare expert, co-founded ASX-listed biotech firms & began his career as a biotech equities analyst at Citigroup.

The author earned a computer science bachelor's degree at the University of Trento, a joint cyber security master's degree through EIT Digital, and a cyber security PhD at Vrije Universiteit of Amsterdam.

BlinkLab focuses on diagnostic areas including ADHD and autism.

BlinkLab's media coverage includes articles and news about its work in autism diagnostics and research collaborations.

BlinkLab's story covers its work in neurological diagnostic evaluation through research and technology.

BlinkLab partners with research institutions, clinical sites, and strategic collaborators to advance autism diagnostics and developmental evaluation.

BlinkLab accepts inquiries about its research, stocks, and collaborations, and provides information about its company and research.

BlinkLab's mission is to advance autism and neurological diagnostic evaluation through digital solutions.